Why did the G-BA assess Trimbow now?
Trimbow was launched onto the German market in 2017. So why did the G-BA assess its benefit now? You likely know that
German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
Trimbow was launched onto the German market in 2017. So why did the G-BA assess its benefit now? You likely know that
Identifying amount of required healthcare The G-BA developed the needs planning directive (German: Bedarfsplanungs-Richtlinie) to give national rules on “how much” SHI-funded
The G-BA has 13 voting members forming the so-called plenum. The representatives of care providers are only entitled to vote on topics
Before a new diagnostic and treatment method can be offered and reimbursed in the outpatient sector, two important steps need to be
In the recent early benefit assessment of nivolumab, the G-BA not only accepted the submitted ITC, but this also resulted in a